Modeling Therapeutic Antibody-Small Molecule Drug-Drug Interactions Using a Three-Dimensional Perfusable Human Liver Coculture Platform
Traditional in vitro human liver cell culture models lose key hepatic functions such as metabolic activity during short-term culture. Advanced three-dimensional (3D) liver coculture platforms offer the potential for extended hepatocyte functionality and allow for the study of more complex biologic i...
Main Authors: | Cosgrove, P. A. (Author), Dunn, R. T. (Author), Stolz, D. B. (Author), Hamadeh, H. (Author), Afshari, C. (Author), McBride, H. (Author), Long, Thomas J (Contributor), Griffith, Linda G (Contributor) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Biotechnology Process Engineering Center (Contributor), Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Mechanical Engineering (Contributor) |
Format: | Article |
Language: | English |
Published: |
American Society for Pharmacology & Experimental Therapeutics (ASPET),
2018-09-04T13:40:43Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Antibody Drug Conjugates as Cancer Therapeutics
by: Pamela A. Trail
Published: (2013-02-01) -
Conjugates of Small Molecule Drugs with Antibodies and Other Proteins
by: Yang Feng, et al.
Published: (2014-01-01) -
Antibody drug discovery: From Idea to Biotherapeutic Molecule
by: Davis, Katherine A. D
Published: (2016) -
Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform
by: Louise Conilh, et al.
Published: (2021-03-01) -
Advances and challenges in therapeutic monoclonal antibodies drug development
by: Mariana Lopes dos Santos, et al.
Published: (2018-11-01)